Evidence map›Paper›PMID 27486852›Full record

ArticlePloS one2016

Tiron Inhibits UVB-Induced AP-1 Binding Sites Transcriptional Activation on MMP-1 and MMP-3 Promoters by MAPK Signaling Pathway in Human Dermal Fibroblasts.

Jing Lu, Jia-Hui Guo, Xue-Liang Tu, Chao Zhang, Mei Zhao, Quan-Wu Zhang, Feng-Hou Gao

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 77 citations in OpenAlex.

  1. Ameliorating Effect ofNutrients · 2022
    Trial
  2. Danggui Buxue Decoction Attenuates HClinical, cosmetic and investigational dermatology · 2026
    Article
  3. Astragaloside IV inhibits MAPK pathway and promotes mitochondrial autophagy in rats with heart failure.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2026
    Article
  4. Article
  5. Article
  6. Ginsenoside-EnrichedPlants (Basel, Switzerland) · 2025
    Article
  7. Profiling the Anti-Photoaging Impact of Titanium Dioxide and Zinc Oxide Nanoparticles: A Focus on Signaling Pathways.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  8. Article
  9. Antiphotoaging effects of solvent fractions isolated fromBiochemistry and biophysics reports · 2024
    Article
  10. Unraveling the Role of Reactive Oxygen Species in T Lymphocyte Signaling.International journal of molecular sciences · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Anti-Photoaging Effect ofMolecules (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Marine drugs · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jing LuInstitute of Oncology, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jia-Hui GuoInstitute of Oncology, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xue-Liang TuYellow River Hospital Attached Henan University of Science and Technology, Sanmeixia, China.
Chao ZhangInstitute of Oncology, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Mei ZhaoDepartment of Reproductive Medicine, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China.
Quan-Wu ZhangDepartment of pathology, Zhengzhou central hospital affiliated to Zhengzhou University, Zhengzhou, China.
Feng-Hou GaoInstitute of Oncology, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Jiao Tong University · CNHenan University of Science and Technology · CNShanghai First Maternity and Infant Hospital · CNZhengzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent research found that Tiron was an effective antioxidant that could act as the intracellular reactive oxygen species (ROS) scavenger or alleviate the acute toxic metal overload in vivo. In this study, we investigated the inhibitory effect of Tiron on matrix metalloproteinase (MMP)-1 and MMP-3 expression in human dermal fibroblast cells. Western blot and ELISA analysis revealed that Tiron inhibited ultraviolet B (UVB)-induced protein expression of MMP-1 and MMP-3. Real-time quantitative PCR confirmed that Tiron could inhibit UVB-induced mRNA expression of MMP-1 and MMP-3. Furthermore, Tiron significantly blocked UVB-induced activation of the MAPK signaling pathway and activator protein (AP)-1 in the downstream of this transduction pathway in fibroblasts. Through the AP-1 binding site mutation, it was found that Tiron could inhibit AP-1-induced upregulation of MMP-1 and MMP-3 expression through blocking AP-1 binding to the AP-1 binding sites in the MMP-1 and MMP-3 promoter region. In conclusion, Tiron may be a novel antioxidant for preventing and treating skin photoaging UV-induced.

Indexed as

Transcription Factor AP-1Ultraviolet Rays1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltAntioxidantsBinding SitesCells, CulturedCytoprotectionDermisFibroblastsHumansMAP Kinase Signaling SystemMatrix Metalloproteinase 1Matrix Metalloproteinase 3Promoter Regions, GeneticSignal TransductionSkin Aging1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltAntioxidantsMatrix Metalloproteinase 1Matrix Metalloproteinase 3MMP1 protein, humanMMP3 protein, humanTranscription Factor AP-1

Identifiers

PMID27486852
PMCPMC4972414
OpenAlexW2493242788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.